Annual report pursuant to Section 13 and 15(d)

Stock-Based Compensation (Tables)

v3.22.4
Stock-Based Compensation (Tables)
 12 Months Ended
Dec. 31, 2022
Equity [Abstract]  
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions The Company has computed the fair value of all options granted using the Black-Scholes-Merton model during the year ended December 31, 2021, using the following assumptions:
Year Ended December 31,
2021
Expected volatility 57%
Expected dividends None
Expected term (years) 7
Risk-free rate
0.97% to 1.27%
Share-based Compensation, Stock Options, Activity The information below summarizes the stock options activity:
Number of
Shares		 Weighted
Average
Exercise
Price		 Weighted
Average
Remaining
Contractual Life		 Aggregate Intrinsic Value
Outstanding at December 31, 2020
 835,601  $ 6.65  6.6 $ 16,153,117 
Granted at market price 48,192  47.01 
Exercised (260,044) 5.84  $ 15,244,054 
Cancelled (28,660) 18.17 
Outstanding at December 31, 2021
 595,089  $ 9.72  5.9 $ 33,336,794 
Granted at market price — 
Exercised (43,380) 8.86  $ 657,058 
Expired (2,795) 28.45 
Cancelled (16,991) 24.96 
Outstanding at December 31, 2022
 531,923  $ 9.20  4.7 $ 3,797,904 
Exercisable at December 31, 2022
 454,315  $ 6.43  4.3 $ 3,772,164 
Vested and expected to vest at December 31, 2022
 528,981  $ 9.07  4.7 $ 3,797,670 
Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity
The information below summaries the restricted stock activity:
Restricted Stock Awards Shares Weighted Average Grant-Date Fair Value per Award
Non-vested at December 31, 2020
 45,595  $ 13.13 
Granted 10,010  58.25 
Vested (26,143) 13.61 
Cancelled (1,742) 20.63 
Non-vested at December 31, 2021
 27,720  28.51 
Granted 68,125  29.47 
Vested (17,240) 29.13 
Cancelled (8,293) 30.51 
Non-vested at December 31, 2022
 70,312  $ 29.05